Feb. 1, 2019
The enzyme NSD2 is overactive in a type of leukemia and certain multiple myelomas, and it’s hard to work with, but researchers at the National Center for Advancing Translational Sciences write in the Journal of Biological Chemistry about their system to speed up the discovery of compounds that will block NSD2 activity.